Cargando…

Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial

BACKGROUND: The main hypothesis of this study is that Oxpentifylline administration will effectively treat erythropoietin- or darbepoietin-resistant anaemia in chronic kidney disease patients. METHODS/DESIGN: Inclusion criteria are adult patients with stage 4 or 5 chronic kidney disease (including d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, David Wayne, Hawley, Carmel Mary, Rosser, Brenda, Beller, Elaine, Thompson, Charles, Fassett, Robert G, Ferrari, Paolo, MacDonald, Stephen, Pedagogos, Eugenie, Cass, Alan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2519060/ https://www.ncbi.nlm.nih.gov/pubmed/18671885 http://dx.doi.org/10.1186/1471-2369-9-8

Ejemplares similares

Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study
por: Irish, Ashley, et al.
Publicado: (2009)

Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial
por: Badve, Sunil V., et al.
Publicado: (2015)

Erythropoietin, uncertainty principle and cancer related anaemia
por: Clark, Otavio, et al.
Publicado: (2002)

Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients
por: Mudge, David W, et al.
Publicado: (2009)

Management of anaemia in CKD—the relative importance of erythropoietin and iron
por: Agarwal, Rajiv
Publicado: (2011)

Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study
por: Lioufas, Nicole, et al.
Publicado: (2019)

Effect of lanthanum carbonate on serum calciprotein particles in patients with stage 3–4 CKD—results from a placebo-controlled randomized trial
por: Tiong, Mark K, et al.
Publicado: (2022)

Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study.
por: Cascinu, S., et al.
Publicado: (1993)

Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia.
por: Barosi, G., et al.
Publicado: (1998)

Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)
por: Barraclough, Katherine A, et al.
Publicado: (2009)

Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia.
por: Thews, O., et al.
Publicado: (1998)

Anaemia at discharge from the intensive care unit is associated with an inappropriate erythropoietin response
por: Bateman, A, et al.
Publicado: (2005)

Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial
por: Ker, Katharine, et al.
Publicado: (2018)

Can losartan and blood pressure control peri arteriovenous fistula creation ameliorate the early associated left ventricular hypertrophic response a randomised placebo controlled trial
por: Zentner, Dominica, et al.
Publicado: (2012)

The Lipid lowering and Onset of Renal Disease (LORD) Trial: A randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease
por: Fassett, Robert G, et al.
Publicado: (2008)

The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse.
por: Joiner, B., et al.
Publicado: (1993)

Response of patients with sickle cell anaemia and end-stage renal disease to erythropoietin treatment
por: Zumrutdal, Aysegul
Publicado: (2010)

Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients (Xanthin): a randomised controlled trial
por: Fassett, Robert G, et al.
Publicado: (2008)

Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: Statistical analysis plan for the WOMAN-2 trial: an international, randomised, placebo-controlled trial
por: Collier, Tim, et al.
Publicado: (2023)

The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications
por: Viecelli, Andrea K., et al.
Publicado: (2015)

An Evaluation of Parents’ Experiences of Patient Engagement in Research to Develop a Digital Knowledge Translation Tool: Protocol for a Multi-Method Study
por: Thompson, Alison P, et al.
Publicado: (2020)

A novel nano-iron supplement to safely combat iron deficiency and anaemia in young children: The IHAT-GUT double-blind, randomised, placebo-controlled trial protocol
por: Pereira, Dora I.A., et al.
Publicado: (2018)

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
por: Miskowiak, Kamilla W, et al.
Publicado: (2010)

Network analysis of TCGA and GTEx gene expression datasets for identification of trait-associated biomarkers in human cancer
por: Chen, Huey-Miin, et al.
Publicado: (2022)

Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial
por: Nichol, Alistair, et al.
Publicado: (2015)

Glia Cell Morphology Analysis Using the Fiji GliaMorph Toolkit
por: Kugler, Elisabeth, et al.
Publicado: (2023)

Age-related pattern and monocyte-acquired haemozoin associated production of erythropoietin in children with severe malarial anaemia in Ghana
por: Abugri, James, et al.
Publicado: (2014)

Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia
por: Duman, Neval, et al.
Publicado: (2014)

Precision Medicine in Erythropoietin Deficiency and Treatment Resistance: A Novel Approach to Management of Anaemia in Chronic Kidney Disease
por: Yugavathy, Nava, et al.
Publicado: (2023)

Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis
por: Thet, Zaw, et al.
Publicado: (2013)

Combination with intravenous iron supplementation or doubling erythropoietin dose for patients with chemotherapy-induced anaemia inadequately responsive to initial erythropoietin treatment alone: study protocol for a randomised controlled trial
por: Chen, Lin, et al.
Publicado: (2016)

Clearing the air: protocol for a systematic meta-narrative review on the harms and benefits of e-cigarettes and vapour devices
por: MacDonald, Marjorie, et al.
Publicado: (2016)

Meta-Analysis of Randomized Controlled Trials on Androgens versus Erythropoietin for Anaemia of Chronic Kidney Disease: Implications for Developing Countries
por: Adamu, B., et al.
Publicado: (2012)

Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis
por: Evans, Marie, et al.
Publicado: (2020)

Can an Open-Label Placebo Be as Effective as a Deceptive Placebo? Methodological Considerations of a Study Protocol
por: Druart, Leo, et al.
Publicado: (2020)

A multimodal intervention to optimise antimicrobial use in residential aged care facilities (ENGAGEMENT): protocol for a stepped-wedge cluster randomised trial
por: Falconer, Nazanin, et al.
Publicado: (2022)

The prevalence, risk factors and outcomes of anaemia in South African pregnant women: a protocol for a systematic review and meta-analysis
por: Dorsamy, Vinogrin, et al.
Publicado: (2020)

Early detection of anaemia in primary care with haemoglobinometry: ANHEMOG clinical trial protocol
por: Luengo, Boris Trenado, et al.
Publicado: (2021)

Decolonization in Sexual and Reproductive Health Research Methods: Protocol for a Scoping Review
por: Stevens-Uninsky, Maya, et al.
Publicado: (2023)

Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial
por: Silveira, C. R. A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l55n7cpnh2lch4le75ujnatdcc